Cartesian Therapeutics, Inc. (RNAC) has a market capitalization of $168.33M and trades at $6.35. The 52-week range is 5.6-15.57.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.3, Earnings Per Share (EPS) of $-5.02, annual revenue of $2.8M.
The stock has a beta of 0.56, operates in the Healthcare sector.
